First Heartland Consultants, Inc. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 67 filers reported holding CTI BIOPHARMA CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
First Heartland Consultants, Inc. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q2 2016$5,000
-37.5%
14,9240.0%0.00%
-66.7%
Q1 2016$8,000
-91.3%
14,924
-80.0%
0.00%
-91.4%
Q4 2015$92,000
-15.6%
74,6240.0%0.04%
-23.9%
Q3 2015$109,000
-25.3%
74,6240.0%0.05%
+15.0%
Q2 2015$146,000
+8.1%
74,6240.0%0.04%
-21.6%
Q1 2015$135,000
-23.3%
74,6240.0%0.05%
-30.1%
Q4 2014$176,000
-2.8%
74,6240.0%0.07%
-8.8%
Q3 2014$181,000
-13.8%
74,6240.0%0.08%
-15.8%
Q2 2014$210,00074,6240.10%
Other shareholders
CTI BIOPHARMA CORP shareholders Q2 2016
NameSharesValueWeighting ↓
FIRST NEW YORK SECURITIES LLC /NY 191,000$345,710,0000.34%
TFS CAPITAL LLC 1,182,304$2,140,0000.21%
TURNER INVESTMENTS LLC 530,100$959,0000.17%
DRW Securities, LLC 486,953$881,0000.14%
Candriam S.C.A. 1,445,000$2,616,0000.05%
First Heartland Consultants, Inc. 74,624$135,0000.05%
WASHINGTON TRUST Co 410,616$743,0000.05%
EAGLE ASSET MANAGEMENT INC 4,332,630$7,842,0000.04%
JW Asset Management, LLC 52,271$95,0000.04%
OXFORD ASSET MANAGEMENT LLP 702,571$1,272,0000.03%
View complete list of CTI BIOPHARMA CORP shareholders